U.S. Food and Drug Administration - CDRH Mobile
Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule

Medical Device Recalls
Class I Recall: Tosoh Bioscience AIA-600 II Analyzers

Date Recall
Initiated:

April 2, 2003

However, FDA first learned of this problem during an inspection of the firm during August - September 2004.

Product:
Tosoh Bioscience AIA-600 II Enzyme Immunoassay Analyzer, software version 3.02.
Use:
This laboratory analyzer is used by laboratory professionals to measure thyroid hormones, cardiac markers including troponin, tumor markers, as well as several other assays.
Recalling Firm:
Tosoh Bioscience, Inc.
347 Oyster Pont Blvd, Suite 201
South San Francisco, CA 94080
Reason for Recall:
This analyzer, with software version 3.02, produced occurrence of false positive and false negative results which could lead to aggravation of the patient’s clinical condition, delay in treatment and potentially death. Patients with small myocardial infarctions are particularly at risk of being negatively affected by false troponin test results. The firm developed a software upgrade but the corrective action was not adequate because the firm did not contact users alerting them of the problem nor did the firm describe how the problems could be corrected.
Public Contact:
Lois Nakayama
Manager, Quality Assurance/Regulatory Affairs
Tosoh Bioscience, Inc.
(650) 615-4970
FDA District:
San Francisco
FDA Comment:

Clinical laboratories are advised to insure they have the latest software installed. The manufacturer should provide the FDA with assurance of validation of its corrective action, including validation of the corrected software, version 3.12. FDA considers that the probability of life threatening consequences is likely to occur by use of an uncorrected analyzer. Class I recalls are the most serious type of recall and involve situations where there is a reasonable probability that use of the product will cause serious injury or death.

 

For additional information on this product recall, see the TOSOH Bioscience, Inc. press release.

Also, for additional information on this product recall, see the FDA Enforcement Report located at: http://www.fda.gov/bbs/topics/enforce/2004/ENF00878.html. Scroll down to "Recalls and Field Corrections: Devices - Class I".

Updated March 7, 2005

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH